about
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery te...
Read More
1.53
0.03
(2.00%)
28,247
XNAS Volume
High vol. this week
XNAS 24 Jun, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Pulmatrix Inc is scheduled for today, for the purpose of Pulmatrix Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..